IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?
about
Interleukin-1 receptor antagonist protects against lipopolysaccharide induced diaphragm weakness in preterm lambsThe Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism.Differential neuroprotective and anti-inflammatory effects of L-type voltage dependent calcium channel and ryanodine receptor antagonists in the substantia nigra and locus coeruleusCalcium dysregulation via L-type voltage-dependent calcium channels and ryanodine receptors underlies memory deficits and synaptic dysfunction during chronic neuroinflammationCaffeine and cardiovascular diseases: critical review of current research.Weak by the machines: muscle motor protein dysfunction - a side effect of intensive care unit treatment.Epinephrine stimulates CXCL1 IL-1α, IL-6 secretion in isolated mouse limb muscle.Salient type 1 interleukin 1 receptor expression in peripheral non-immune cells.Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle.Mechanism of ICU-acquired weakness: muscle contractility in critical illness
P2860
Q28546032-7244D87E-8FF6-4DE8-8742-273215D093A8Q34483183-590D750E-A004-4605-A864-2D04E1F30FDDQ34603211-322DD462-A2F4-494D-8A05-37BC3584CCA3Q35108124-3531978B-B598-45A1-9D6B-F29C4A02A706Q35226213-9F59E12E-C7FE-4C2B-9684-DD1A29DF6E25Q38757122-7FC414B1-C8B5-4065-84EE-0AB16571C3ECQ39225991-D99F71D7-AC07-4676-9ED4-CFF08B8B6DF3Q47101911-F5BFB718-E643-4FAA-BF9D-85F57A1BA8F4Q47863651-30DAF020-5A6F-4F53-97F7-F8C622ED410BQ48053644-9B69F2FD-8932-41B3-BEA5-6BF9F3C11B52Q58476266-4FB509F0-08B7-43CA-87C1-93369E6B68B3
P2860
IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@ast
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@en
type
label
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@ast
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@en
prefLabel
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@ast
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@en
P2093
P2860
P50
P356
P1476
IL-1α reversibly inhibits skel ...... for critical illness myopathy?
@en
P2093
Andreas Buttgereit
Anette Wirth-Hücking
Barbara Reischl
Cornelia Weber
Fabian Polyak
Frederic von Wegner
Joshua N Edwards
Patrick Most
P2860
P304
P356
10.1165/RCMB.2013-0059OC
P577
2014-06-01T00:00:00Z